Why Enovis Corporation’s (ENOV) Stock Is Up 18.46%
As of Thursday, November 05, Enovis Corporation’s ENOV share price has surged by 18.46%, which has investors questioning if this is right time to sell.Michael Rose
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Tudor Pop
Rosalio Madrigal
Tudor Pop
Rosalio Madrigal
| Share Statistics | ENOV | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,469.5 | $363.7 | 52% |
|
| Shares Out (Mil) | 58.5 | 41.1 | 51% |
|
| Institutional Ownership | 98.5% | 82.7% | 79% |
|
| Float (Mil) | 51.4 | 36.7 | 47% |
|
| Beta | 1.42 | 0.89 | 79% |
|
| Avg Daily Volume (000s) | 1,191 | 326 | 72% |
|
| Price Change (52-week) |
(6.3%) | 54.6% | 48% |
|
| Growth | ENOV | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 14.9% | 11.8% | 73% |
|
| Net Income (5yr) | (97.2%) | (5.8%) | 2% |
|
| EPS (5yr) | (89.2%) | 10.6% | 1 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (2.0%) | (15.6%) | 63% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 13 | 13 | 13 | |
| Current EPS | $1.029 | $3.698 | $3.464 | |
| Month Ago EPS | $1.067 | $3.627 | $3.543 | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 1 | |
| Three Months Ago EPS | $1.074 | $3.640 | $4.015 | |
| Year/Year Chg | 6,331% | (117.8%) | (118.3%) | |
| Financials | ENOV | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2,306 | $123 | 62% |
|
| Net Income (TTM) (Mil) | ($527) | ($9) | 2% |
|
| EPS (TTM) | ($9.181) | ($0.300) | 5% |
|
| Operating Cash Flow (TTM) (Mil) | $259 | ($1) | 62% |
|
| Net Cash Flow (TTM) (Mil) | ($21) | $2 | 28% |
|
| Long-Term Debt (Q1) (Mil) | $1,283 | $21 | 69% |
|
| Enterprise Value (Q1) (Mil) | $2,943 | $381 | 54% |
|
| Valuation | ENOV | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.98 | 2.41 | 29% |
|
| P/E | na | 25.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | ENOV | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 61.3% | 59.5% | 74% |
|
| Net Margin | (22.9%) | (5.0%) | 15% |
|
| ROA | (12.9%) | (10.4%) | 23% |
|
| ROE | (30.0%) | (8.4%) | 20% |
|
| Liabilities to Assets | 60.0% | 45.8% | 54% |
|
| F-Score | 5 | 4 | 50% |
|
Passing Stock Screens
As of 11/20/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 6.9% |
| +/- S&P 500: | -0.5 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors